The KKR Medicover India acquisition marks one of the largest private equity-driven healthcare transactions in India in recent years. AZB & Partners advised KKR on the acquisition of a 100 percent stake in Sahrudaya Health Care Private Limited, the parent entity behind Medicover Hospitals in India, for €1.2 billion. Four law firms — McDermott Will & Emery Schulte, Cyril Amarchand Mangaldas, Trilegal, and AZB & Partners — along with Advokatfirman Vinge, provided legal counsel across the transaction.
Introduction
KKR & Co. agreed to acquire Medicover AB‘s Indian hospital operations; the disposal gives Medicover Hospitals India an enterprise value of €1.2 billion. The transaction involves KKR acquiring the entire stake held by Medicover in Sahrudaya Health Care Private Limited, which is the parent corporate entity behind the Medicover Hospitals network in India. The transaction will be completed after receiving regulatory approvals.
Medicover India is a multi-specialty hospital network operating 26 hospitals across Telangana, Andhra Pradesh, Karnataka and Maharashtra.
Deal Value
The equity consideration for the transaction is approximately €1.2 billion. The disposal gives Medicover Hospitals India an enterprise value of €1.2 billion ($1.4 billion), and the sale will generate gross cash proceeds of €740 million, helping Medicover accelerate its strategic push into Poland, Germany and Romania.
Legal Teams Involved
McDermott Will & Emery Schulte — Lead Counsel for Medicover and Certain Minority Shareholders
McDermott Will & Emery Schulte served as lead counsel for Medicover and certain minority shareholders on the overall transaction. The team comprised:
- Fatema Orjela — Partner
- Zoe Woodhouse — Counsel
- Lisa Goransson — Relationship Partner (Corporate/M&A)
- Arjun Sehgal — Associate
- Raees Khan — Associate
Cyril Amarchand Mangaldas — Counsel for Medicover
Cyril Amarchand Mangaldas also represented Medicover on this transaction. The team comprised:
- Reeba Chacko — Senior Partner (transaction lead)
- Kota Chandan — Partner (transaction lead)
- Yash Chadha — Associate
- Lakshmi Prakash — Partner (advised on third-party financing repayment structuring and ECB assignment)
- Dipti Khatri — Principal Associate (supported on ESOP settlement mechanism)
- Bharath Reddy — Partner (advised on ESOP settlement mechanism)
- Arpita Sengupta — Partner (advised on the transitional license agreement)
- Sharada Ramachandra — Partner (advised on certain corporate matters)
Trilegal — Counsel for Minority Shareholders of Medicover India
Trilegal advised the minority shareholders of Medicover India on the sale of their stake in the company to KKR, advising on transaction structuring and definitive documents. The team comprised:
- Nishant Parikh — Partner
- Ashwin Sapra — Partner
- Sanjam Arora — Partner
- Niharika Choudhary — Counsel
- Kartik Jain — Counsel
- Averal Sibal — Senior Associate
- Kashish Khandelwal — Associate
AZB & Partners — Counsel for KKR
AZB & Partners advised KKR on this transaction. The transaction team consisted of Zia Mody (Managing Partner), Nandish Vyas (Senior Partner), Jeet Chaudhuri (Partner), Malini Raju (Partner), Anish Patel (Senior Associate), Tanay Chopra (Senior Associate), Shreshth Bhartia (Senior Associate) and Prannathi Ajith Kumar (Senior Associate).
Advokatfirman Vinge
Advokatfirman Vinge was also involved in this transaction. The specific mandate and team members were not disclosed.
Significance and Impact
The deal marks KKR’s third hospital acquisition in India in three years, further expanding its presence in the country’s healthcare sector. KKR will keep Medicover India as a standalone business rather than integrating it with its existing hospital platforms, HCG and Baby Memorial.
For the seller, the strategic rationale is equally clear. Medicover’s ownership in Medicover India amounts to 66.1 percent, while minority shareholders hold 33.9 percent; the deal would help Medicover focus strategically and operationally on Poland, Germany, and Romania.
The transaction is also notable for its legal complexity, drawing in cross-border counsel on both the buy side and sell side. The involvement of McDermott Will & Emery Schulte as lead international counsel, alongside multiple Indian law firms advising different stakeholder groups — Medicover, its minority shareholders, and KKR — reflects the multi-layered ownership structure of Sahrudaya Health Care. The engagement of Advokatfirman Vinge, a Swedish firm, underscores the cross-jurisdictional dimension given Medicover AB’s Stockholm headquarters.
For further context on law firm deal activity, see the Deal Meter.
The KKR–Medicover India transaction is a landmark deal for India’s private healthcare sector, valued at €1.2 billion and backed by a formidable multi-firm legal advisory structure. The transaction remains subject to regulatory approvals. Completion of this acquisition will further consolidate KKR’s standing as one of the most active private equity investors in Indian healthcare.
Disclaimer: This article is for informational purposes only and does not constitute legal advice. It is based on the details provided and publicly available sources.
